Literature DB >> 23103427

RAGE in tissue homeostasis, repair and regeneration.

Guglielmo Sorci1, Francesca Riuzzi, Ileana Giambanco, Rosario Donato.   

Abstract

RAGE (receptor for advanced glycation end-products) is a multiligand receptor of the immunoglobulin superfamily involved in inflammation, diabetes, atherosclerosis, nephropathy, neurodegeneration, and cancer. Advanced glycation end-products, high mobility group box-1 (amphoterin), β-amyloid fibrils, certain S100 proteins, and DNA and RNA are RAGE ligands. Upon RAGE ligation, adaptor proteins (i.e., diaphanous-1, TIRAP, MyD88 and/or other as yet unidentified adaptors) associate with RAGE cytoplasmic domain resulting in signaling. However, RAGE activation may not be restricted to pathological statuses, the receptor being involved in tissue homeostasis and regeneration/repair upon acute injury, and in resolution of inflammation. RAGE effects are strongly dependent on the cell type and the context, which may condition therapeutic strategies aimed at reducing RAGE signaling.
Copyright © 2012 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23103427     DOI: 10.1016/j.bbamcr.2012.10.021

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  80 in total

Review 1.  Multifarious diagnostic possibilities of the S100 protein family: predominantly in pediatrics and neonatology.

Authors:  Anna Medkova; Josef Srovnal; Jarmila Potomkova; Jana Volejnikova; Vladimir Mihal
Journal:  World J Pediatr       Date:  2018-06-01       Impact factor: 2.764

2.  High-mobility group box 1 inhibits HCO3- absorption in the medullary thick ascending limb through RAGE-Rho-ROCK-mediated inhibition of basolateral Na+/H+ exchange.

Authors:  Bruns A Watts; Thampi George; Andrew Badalamenti; David W Good
Journal:  Am J Physiol Renal Physiol       Date:  2016-06-29

3.  Empathy in stroke rats is modulated by social settings.

Authors:  Kazutaka Shinozuka; Naoki Tajiri; Hiroto Ishikawa; Julian P Tuazon; Jea-Young Lee; Paul R Sanberg; Sydney Zarriello; Sydney Corey; Yuji Kaneko; Cesario V Borlongan
Journal:  J Cereb Blood Flow Metab       Date:  2019-08-01       Impact factor: 6.200

Review 4.  Profilin: many facets of a small protein.

Authors:  Rhonda J Davey; Pierre Dj Moens
Journal:  Biophys Rev       Date:  2020-07-13

Review 5.  Regulation and dysregulation of astrocyte activation and implications in tumor formation.

Authors:  Chunzhang Yang; Shervin Rahimpour; Albert C H Yu; Russell R Lonser; Zhengping Zhuang
Journal:  Cell Mol Life Sci       Date:  2013-02-19       Impact factor: 9.261

6.  Detection of RAGE expression and its application to diabetic wound age estimation.

Authors:  Xin-Yi Ji; Yang Chen; Guang-Hua Ye; Miao-Wu Dong; Ke-Zhi Lin; Jun-Ge Han; Xiang-Ping Feng; Xing-Biao Li; Lin-Sheng Yu; Yan-Yan Fan
Journal:  Int J Legal Med       Date:  2017-01-11       Impact factor: 2.686

7.  Prothrombin is a binding partner of the human receptor of advanced glycation end products.

Authors:  Genny Degani; Alessandra Altomare; Stefania Digiovanni; Beatrice Arosio; Guenter Fritz; Angela Raucci; Giancarlo Aldini; Laura Popolo
Journal:  J Biol Chem       Date:  2020-07-14       Impact factor: 5.157

8.  Circulating soluble advanced glycation end product is inversely associated with the significant risk of developing cancer: evidence from a meta-analysis.

Authors:  Lan He; Hongguang Bao; Jing Xue; Lihong Zheng; Qi Zhang; Lei Sun; Hongming Pan
Journal:  Tumour Biol       Date:  2014-05-30

9.  Dietary advanced glycation end-products, its pulmonary receptor, and high mobility group box 1 in aspiration lung injury.

Authors:  Peter J Smit; Weidun A Guo; Bruce A Davidson; Barbara A Mullan; Jadwiga D Helinski; Paul R Knight
Journal:  J Surg Res       Date:  2014-04-08       Impact factor: 2.192

10.  A pilot study evaluating protein abundance in pressure ulcer fluid from people with and without spinal cord injury.

Authors:  Laura E Edsberg; Jennifer T Wyffels; Rajna Ogrin; B Catharine Craven; Pamela Houghton
Journal:  J Spinal Cord Med       Date:  2014-06-26       Impact factor: 1.985

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.